Patients lack knowledge on radiation in medical imaging
More than half of patients did not know that chest CT delivers more radiatio...Read more on AuntMinnie.comRelated Reading: Consider the esophagus when it comes to breast cancer radiotherapy Radiology contributes to high spending costs in cancer care Mammography, DBT safe for accidental exam during pregnancy Radiation therapy for breast cancer boosts risk of heart disease AI helps reduce cancer PET imaging time and dose (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 13, 2021 Category: Radiology Source Type: news

ASCO Esophageal Cancer Guidance Updated to Include Nivolumab ASCO Esophageal Cancer Guidance Updated to Include Nivolumab
The ASCO guidance has been updated to recommend adjuvant nivolumab in patients with residual disease following data from CheckMate 577 -- although caveats remain.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 11, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Consider the esophagus when it comes to breast cancer radiotherapy
Routinely avoiding the esophagus during radiation therapy for breast cance...Read more on AuntMinnie.comRelated Reading: Chronic stress linked to breast cancer treatment, survival outcomes Radiology contributes to high spending costs in cancer care AI of MRI shows success in ruling out cancer in dense breasts Radiomics model helps differentiate breast lesions on MRI Breast MRI can be cost-effective in 4-year screening intervals (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 11, 2021 Category: Radiology Source Type: news

New Opdivo/Yervoy Mesothelioma Clinical Trial Begins Soon
A novel clinical trial involving the immunotherapy combination of Opdivo and Yervoy will open soon in Chicago. The goal is to study the drugs’ efficacy when added to surgery for patients with peritoneal mesothelioma cancer. The single-center, phase II clinical trial follows a recent report detailing the impressive three-year effectiveness of the drug combination when used for unresectable pleural mesothelioma. Bristol Myers Squibb manufactures Opdivo and Yervoy, known generically as nivolumab and ipilimumab. The U.S. Food and Drug Administration approved the combination for pleural mesothelioma in 2020, making ...
Source: Asbestos and Mesothelioma News - October 7, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

Risk factors associated with suicide among esophageal carcinoma patients from 1975 to 2016 - Chen C, Lin H, Xu F, Liu J, Cai Q, Yang F, Lv L, Jiang Y.
Throughout the world, esophageal cancer patients had a greater suicidal risk compared with ordinary people. Thus, we aimed to affirm suicide rates, standardized mortality rates, and underlying suicide-related risk factors of esophageal cancer patients. Pat... (Source: SafetyLit)
Source: SafetyLit - September 24, 2021 Category: International Medicine & Public Health Tags: Risk Factor Prevalence, Injury Occurrence Source Type: news

Case Western Reserve technology licensee Lucid Diagnostics files IPO plan
Lucid is focused on patients with gastroesophageal reflux disease, also known as chronic heartburn or acid reflux, who are at risk of developing esophageal cancer. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - September 23, 2021 Category: Health Management Authors: I-Chun Chen Source Type: news

Case Western Reserve technology licensee Lucid Diagnostics files IPO plan
Lucid is focused on patients with gastroesophageal reflux disease, also known as chronic heartburn or acid reflux, who are at risk of developing esophageal cancer. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 23, 2021 Category: Biotechnology Authors: I-Chun Chen Source Type: news

RAVmed unit Lucid Diagnostics files IPO plan
Lucid is focused on patients with gastroesophageal reflux disease, also known as chronic heartburn or acid reflux, who are at risk of developing esophageal cancer. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 23, 2021 Category: Pharmaceuticals Authors: I-Chun Chen Source Type: news

RAVmed unit Lucid Diagnostics files IPO plan
Lucid is focused on patients with gastroesophageal reflux disease, also known as chronic heartburn or acid reflux, who are at risk of developing esophageal cancer. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 23, 2021 Category: Biotechnology Authors: I-Chun Chen Source Type: news

Can Cannabis Help Your Gut?
When Joe Silverman developed Crohn’s disease at age 21, the symptoms started out mild. While the sight of blood in his stools initially freaked him out, what really bothered him was the frequent abdominal pain and bloating that occurred as his condition progressed to moderate and then severe. Dietary changes didn’t make a difference, so he began taking prescription oral anti-inflammatory drugs that are often used to treat certain bowel diseases, which alleviated but didn’t eliminate his discomfort. He started using prescription steroid suppositories to cope with flare-ups of the inflammatory bowel disease...
Source: TIME: Health - September 23, 2021 Category: Consumer Health News Authors: Stacey Colino Tags: Uncategorized Source Type: news

Hope for new cancer drug that could extend patients' lives by four months
PATIENTS with late-stage oesophageal cancer could get more time with their loved ones after a new treatment was approved for the NHS. (Source: Daily Express - Health)
Source: Daily Express - Health - September 18, 2021 Category: Consumer Health News Source Type: news

New Report Details 9/11 Health Effects on FDNY Firefighters
A recent report from the Fire Department of New York World Trade Center Health Program outlines the 9/11-related health effects firefighters are dealing with 20 years later. Approximately 410,000 first responders spent the days and weeks after 9/11 inhaling toxic materials as they helped save lives from the collapse of the Twin Towers. Almost 3,000 people died on Sept. 11, 2001, but in the 20 years since, another 4,343 survivors have died due to related health effects. FDNY has felt the impact of delayed illness, as well. While 343 FDNY firefighters died on 9/11, another 254 have died since then from 9/11-related dis...
Source: Asbestos and Mesothelioma News - September 9, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

Virginia woman SUES Zantac for heartburn drug that gave her esophageal cancer
(Natural News) A woman from Ridgeway, Virginia, is the latest to file a lawsuit against the makers of heartburn medication Zantac, claiming that the drug gave her esophageal cancer. Deborah Haskins said that she began using Zantac in 2005, taking at least one 75mg tablet a day. She was later diagnosed with esophageal cancer, apparently due... (Source: NaturalNews.com)
Source: NaturalNews.com - August 26, 2021 Category: Consumer Health News Source Type: news

AI can lend a hand in diagnosis, prognosis of oral SCC
Radiology and pathology artificial intelligence (AI) algorithms can help i...Read more on AuntMinnie.comRelated Reading: PET/CT shows promise predicting outcomes in head, neck cancer FDG-PET/CT may increase survival in SCC patients CT radiomics predicts esophageal cancer outcomes PET radiomics tailor head/neck cancer treatment Later PET/CT follow-up helps for oropharyngeal cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 19, 2021 Category: Radiology Source Type: news

Gastric Cardia Culprit in Barrett's Esophagus, Transformative Mechanism Identified Gastric Cardia Culprit in Barrett's Esophagus, Transformative Mechanism Identified
A series of lab experiments pinpointed the gastric cardia as the cellular origin of Barrett's esophagus (BE) and showed how undifferentiated BE cells can turn malignant.Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - August 18, 2021 Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news

Coffee protects against liver cancer while alcohol is linked with numerous cancers
Alcohol consumption is a major risk factor for several cancers including head & neck (mouth, pharynx, larynx), oesophageal and bowel cancer - as well as the more widely known links to breast and liver cancer - according to a new study funded by World Cancer Research Fund (WCRF)(1), and published this week in Nature Communications. The study also found increased coffee consumption was associated with a lower risk of developing liver cancer and basal cell carcinoma of the skin. (Source: World Pharma News)
Source: World Pharma News - August 4, 2021 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

FDA Grants Orphan Drug Designation to Novel Mesothelioma Treatment
The U.S. Food and Drug Administration has granted orphan drug designation to ONCOFID-P for the treatment of malignant pleural mesothelioma, a step toward another potential therapy option for patients. ONCOFID-P is an innovative drug conjugate already in advanced clinical development for the treatment of invasive bladder cancer. The mesothelioma designation is based on preclinical data showing high antitumor activity in laboratory and mice models. Fidia Farmaceutici, a multinational research company based in Italy, announced the latest FDA designation, which is designed to encourage the development of novel drugs, par...
Source: Asbestos and Mesothelioma News - July 28, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

Alcohol caused 740,000 cancer cases globally last year – study
Researchers behind estimate say more needs to be done to raise public awareness of linkAlcohol is estimated to have caused more than 740,000 cancer cases around the world last year, and experts say more needs to be done to highlight the link.There is strong evidence that alcohol consumption can cause various cancers including those of the breast, liver, colon, rectum, oropharynx, larynx and oesophagus. Research suggests that evenlow levels of drinking can increase the risk.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - July 13, 2021 Category: Science Authors: Nicola Davis Science correspondent Tags: Alcohol Cancer Medical research Breast cancer Health Science Society Source Type: news

AI software may help spot early signs of oesophageal cancer
Software in use at an NHS trust could prove a breakthrough in diagnosing one of the deadliest forms of cancerOne of the NHS ’s leading hospital trusts has begun using artificial intelligence to help detect cancer in the gullet, whichkills 8,000 Britons a year. It is hoped the technology will increase the number of cases of cancer in the oesophagus that doctors spot.Oesophageal cancer is one of the deadliest forms of cancer. It is hard to detect, particularly in its early stages, and many people who get it die soon after their diagnosis. Fewer than one in five of those diagnosed are still alive five years later.Contin...
Source: Guardian Unlimited Science - July 1, 2021 Category: Science Authors: Denis Campbell Health policy editor Tags: Cancer NHS Artificial intelligence (AI) Cancer research Medical research Health Science Society Technology UK news Source Type: news

Blood test for personalized cancer treatment
(Flinders University) A blood test to help guide the treatment of esophageal, stomach and bowel cancers will be evaluated in a new Flinders University trial set to get underway. The trial is thanks to a federal government grant of almost $2 million announced yesterday, with Flinders University awarded funding for three projects, totaling $5.8 million. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 1, 2021 Category: Cancer & Oncology Source Type: news

‘Sponge on a string’ test will help pinpoint gullet cancer
UK trials begin for test that detects risk of oesophageal diseaseTrials of a new weapon in the battle against cancer are to be launched across Britain next month. The cytosponge – a sponge on a string – is to be used to pinpoint individuals at risk of developing oesophageal cancer.The aim is to tackle one of Britain ’s most pernicious illnesses. Oesophageal cancer is often diagnosed late in its development when it is difficult to treat. It is the sixth most common cause of cancer deaths in the UK with only 15% of patients surviving five years after diagnosis and is more common in older people.Continue rea...
Source: Guardian Unlimited Science - June 27, 2021 Category: Science Authors: Robin McKie Tags: Cancer research Medical research Science UK news Source Type: news

Investigating a better treatment sequence for esophageal cancer
(University of Colorado Anschutz Medical Campus) University of Colorado Cancer Center member Martin McCarter, MD, is investigating whether a new treatment sequence will result in better outcome for patients with esophageal cancer. As they await the results of a group of clinical trials, McCarter and other CU researchers looked at data from the National Cancer Database to identify other patients who have undergone the new sequence, and what the outcomes for those patients were. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 22, 2021 Category: Cancer & Oncology Source Type: news

Running in the blood: Blood lipids are linked to cancer, but depending on family history
(Cactus Communications) Several studies have associated blood lipids with different types of cancer like that of the food pipe or 'esophagus,' but much remains to be understood, to apply this knowledge clinically. A group of Chinese scientists has successfully advanced this line of research, by identifying the role of family history in modifying the association between blood lipids and risk of developing esophageal malignant lesions, according to a new study published in Chinese Medical Journal. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 21, 2021 Category: Cancer & Oncology Source Type: news

Esophageal Cancer Responsive to Immune Cell Therapy + Nivolumab Esophageal Cancer Responsive to Immune Cell Therapy + Nivolumab
This report suggests that a combination of adoptive immune cell therapy and an immune checkpoint inhibitor might be a possible treatment strategy for advanced esophageal cancer.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 17, 2021 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

FDA approves nivolumab in combination with chemotherapy for metastatic gastric cancer and esophageal adenocarcinoma
Hematology / Oncology (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 10, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Immunotherapy Likely New Standard in Advanced Esophageal Cancer Immunotherapy Likely New Standard in Advanced Esophageal Cancer
Nivolumab with chemotherapy or nivolumab with ipilimumab improved overall survival as compared with standard chemotherapy in advanced ESCC.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 3, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA OKs Nivolumab After Surgery for Esophageal or GEJ Cancer FDA OKs Nivolumab After Surgery for Esophageal or GEJ Cancer
The adjuvant use of nivolumab has been described as practice-changing in patients with resected esophageal or gastroesophageal junction cancer who have received chemoradiotherapy before surgery.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 20, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news

FDA approves nivolumab for resected esophageal or GEJ cancer
Hematology / Oncology News Burst (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 20, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

As MRI strength increases, so do concerns about magnet safety
As the push toward stronger and faster MRI scanners continues, so does concer...Read more on AuntMinnie.comRelated Reading: Tips and tricks for finding lithium batteries in the esophagus on MRI Bedside point-of-care MRI appears convenient and accurate AI, radiomics can predict cancer in lesions found on breast MRI Ensuring patient privacy is key in MRI research projects 7T MRI shows promise for sports imaging of injured athletes (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 20, 2021 Category: Radiology Source Type: news

U.S. FDA Approves Opdivo (nivolumab) as Adjuvant Treatment of Completely Resected Esophageal or Gastroesophageal Junction Cancer in Patients who have Received Neoadjuvant Chemoradiotherapy
PRINCETON, N.J.--(BUSINESS WIRE) May 20, 2021 -- Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved Opdivo® (nivolumab, injection for intravenous use) for the adjuvant treatment of... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 20, 2021 Category: Drugs & Pharmacology Source Type: news

FDA Approves Opdivo (nivolumab) as Adjuvant Treatment of Completely Resected Esophageal or Gastroesophageal Junction Cancer in Patients who have Received Neoadjuvant Chemoradiotherapy
PRINCETON, N.J.--(BUSINESS WIRE) May 20, 2021 -- Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved Opdivo® (nivolumab, injection for intravenous use) for the adjuvant treatment of... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 20, 2021 Category: Drugs & Pharmacology Source Type: news

How Long Do You Live After Being Diagnosed With Esophageal Cancer?
Title: How Long Do You Live After Being Diagnosed With Esophageal Cancer?Category: Diseases and ConditionsCreated: 5/14/2021 12:00:00 AMLast Editorial Review: 5/14/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 14, 2021 Category: Cancer & Oncology Source Type: news

Esophageal Cancer: Preop Chemoradiotherapy Benefit for 10 Years Esophageal Cancer: Preop Chemoradiotherapy Benefit for 10 Years
Among patients with locally advanced resectable esophageal or junctional cancer, the overall survival benefit conferred by preoperative chemoradiotherapy persists for at least 10 years.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 13, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Michael Atkinson obituary
My mentor and friend Michael Atkinson, who has died aged 95, was for many years professor of gastroenterology at the University of Nottingham, where one of his most important contributions was the development of the Atkinson tube, which helps people with oesophageal cancer to swallow.Born in Rawdon, just outside Leeds, to Herbert, a plumbers ’ merchant, and his wife, Janet (nee Palliser), a postmistress, Michael went to Aireborough grammar school in West Yorkshire, then University College London for his medical education during the second world war.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - May 13, 2021 Category: Science Authors: John Bennett Tags: Medical research Medicine Cancer research Hospitals Health NHS Leeds University of Nottingham Source Type: news

Esophageal cancers resurrect ancient retroviruses hidden in our genome
(Columbia University Irving Medical Center) Scientists have found that many esophageal cancers turn on ancient viral DNA embedded in our genome, a finding that could lead to improvements in immunotherapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 10, 2021 Category: International Medicine & Public Health Source Type: news

Increased use of minimally invasive non-endoscopic tests for Barrett's esophagus screening
(American College of Physicians) The authors of a new commentary from Mayo Clinic suggest that more extensive use of minimally invasive non-endoscopic tests for Barrett's esophagus (BE) screening could impact early detection and prevention of esophageal adenocarcinoma (EAC), a particularly deadly form of cancer. This is important because BE, the only known precursor to esophageal cancer, is often asymptomatic. Their commentary is published in Annals of Internal Medicine. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 3, 2021 Category: Infectious Diseases Source Type: news

What Are the Stages of Esophageal Cancer?
Title: What Are the Stages of Esophageal Cancer?Category: Diseases and ConditionsCreated: 4/30/2021 12:00:00 AMLast Editorial Review: 4/30/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 30, 2021 Category: Cancer & Oncology Source Type: news

Humana partially reverses PET/CT policy
Humana will begin covering PET/CT imaging for gastric and esophageal oncologi...Read more on AuntMinnie.comRelated Reading: FDG-PET/CT may increase survival in SCC patients FDG-PET/CT effective for staging in new breast cancer SNMMI provides update on COVID-19 vaccine and PET/CT PET/CT shows link between stress and fatal heart condition Nuclear medicine groups oppose Humana PET/CT policy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 27, 2021 Category: Radiology Source Type: news

Sculpting radiation beam spares lung cancer patients from severe, disabling complication
(Massachusetts General Hospital) The use of a novel esophagus-sparing technique reduces the rate of severe inflammation of the esophagus in patients with localized lung cancer receiving high-dose radiation and concurrent chemotherapy. Severe esophagitis was reduced despite tumors located within 1 centimeter of the esophagus, with no increased risk in local tumor recurrence. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 22, 2021 Category: Cancer & Oncology Source Type: news

Esophage cancer: Discovery of the mechanisms involved
(Universit é libre de Bruxelles) Publication in Cell Stem Cell: Researchers at the Universit é libre de Bruxelles, ULB uncover a new mechanism involved in the development of metaplasia in the oesophagus. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 21, 2021 Category: International Medicine & Public Health Source Type: news

Opdivo Plus Chemotherapy Approved for Treatment of Gastric Cancer
TUESDAY, April 20, 2021 -- Opdivo (nivolumab) is now approved for the treatment of advanced or metastatic gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma, the U.S. Food and Drug Administration announced Friday. The... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 20, 2021 Category: Pharmaceuticals Source Type: news

How Curable Is Cancer of the Esophagus?
Title: How Curable Is Cancer of the Esophagus?Category: Diseases and ConditionsCreated: 4/19/2021 12:00:00 AMLast Editorial Review: 4/19/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 19, 2021 Category: Cancer & Oncology Source Type: news

FDA Approves Opdivo (nivolumab) in Combination with Chemotherapy for Patients with Advanced or Metastatic Gastric Cancer, Gastroesophageal Junction Cancer, and Esophageal Adenocarcinoma Regardless of PD-L1 Expression Status
PRINCETON, N.J.--(BUSINESS WIRE)-- April 16, 2021 Opdivo is the first and only immunotherapy in combination with chemotherapy to deliver superior overall survival versus chemotherapy alone in a trial of this patient population1 U.S. Food and... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - April 16, 2021 Category: Drugs & Pharmacology Source Type: news

FDA approves nivolumab in combination with chemotherapy for metastatic gastric cancer and esophageal adenocarcinoma
Hematology / Oncology (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 16, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Consumer Health: Treating esophageal cancer
April is Esophageal Cancer Awareness Month, which makes this a good time to learn more about treating esophageal cancer, the sixth most common cause of cancer deaths worldwide. Esophageal cancer is more common among men than women, and it can occur anywhere along the esophagus. Signs and symptoms of esophageal cancer include difficulty swallowing, unexplained [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 12, 2021 Category: Databases & Libraries Source Type: news

FDA D.I.S.C.O. Burst Edition: FDA approval of Keytruda (pembrolizumab) for patients with metastatic or locally advanced esophageal or gastroesophageal carcinoma
FDA D.I.S.C.O. Burst Edition: FDA approval of Keytruda (pembrolizumab) in combination with platinum and fluoropyrimidine-based chemotherapy for patients with metastatic or locally advanced esophageal or gastroesophageal carcinoma. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 9, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Esophageal Cancer: An Updated Review Esophageal Cancer: An Updated Review
The incidence of esophageal cancer is on the rise. Review its epidemiology, risk factors, diagnosis and management in this update.Southern Medical Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 5, 2021 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

Mayo Clinic Q & amp;A podcast: Esophageal cancer is one of the deadliest cancers
Esophageal cancer occurs in the esophagus -- a long, hollow tube that runs from the throat to the stomach -- and can occur anywhere along the esophagus. Men are more likely to develop esophageal cancer than women. While treatable, esophageal cancer is rarely curable. "It's an uncommon cancer," says Dr. Shanda Blackmon, a Mayo Clinic general thoracic surgeon. [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 5, 2021 Category: Databases & Libraries Source Type: news

Adjuvant Nivolumab Beneficial in Esophageal, GE Junction Cancer
Disease - free survival significantly longer in patients with resected esophageal, gastroesophageal junction cancer (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 1, 2021 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Pharmacy, Journal, Source Type: news

Drug Could Be a ‘ Game - Changer ’ in Fighting Esophageal Cancers
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 1, 2021 Category: Cancer & Oncology Tags: Oncology, Pharmacy, News, Source Type: news